Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
116076 trials found · Page 266 of 5804
-
Could a weekly injection free people with type 1 diabetes from carb counting?
Disease control Recruiting nowThis research study is testing whether a weekly medication called tirzepatide can help adults with type 1 diabetes use their insulin pump more easily, specifically by reducing or eliminating the need to count carbohydrates at meals. People with type 1 diabetes must take insulin …
Phase: PHASE2, PHASE3 • Sponsor: McGill University Health Centre/Research Institute of the McGill University Health Centre • Aim: Disease control
Last updated Jun 27, 2026 12:37 UTC
-
Magic mushroom therapy aims to ease cancer Patients' fear and sadness
Symptom relief Recruiting nowThis phase II trial tests the safety, side effects and how well group retreat psilocybin therapy works for the treatment of anxiety and depression in patients with solid tumors that have spread from where they first started (primary site) to other places in the body (metastatic) …
Phase: PHASE2 • Sponsor: University of Washington • Aim: Symptom relief
Last updated Jun 27, 2026 13:00 UTC
-
New hope for rare GIST: targeted pill shows promise in early trial
Disease control Recruiting nowThe purpose of this study is to determine how effective the drug pemigatinib is as a treatment option for advanced succinate dehydrogenase (SDH)-deficient gastrointestinal stromal tumors(GIST). This study will also assess the side effects associated with pemigatinib and evaluate …
Phase: PHASE2 • Sponsor: Dana-Farber Cancer Institute • Aim: Disease control
Last updated Jun 27, 2026 12:37 UTC
-
New hope for liver cancer: experimental drug HH-009 enters human trials
Disease control Recruiting nowThis is a randomized, open-label, multicenter Phase Ib/II registration trial designed to evaluate the efficacy and safety of HH-009 in patients with FGF19-positive hepatocellular carcinoma (HCC). The study will also assess pharmacokinetics, pharmacodynamics, immunogenicity, and e…
Phase: PHASE1, PHASE2 • Sponsor: Huahui Health • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
Could a common antibiotic help stroke patients walk again?
Disease control Recruiting nowAcute ischemic stroke (AIS) is a leading cause of mortality and long-term disability worldwide. Among these, stroke caused by large vessel occlusion (LVO) are associated with particularly poor outcomes. Multiple randomized controlled trials have demonstrated that endovascular thr…
Phase: PHASE2, PHASE3 • Sponsor: Xiang Luo • Aim: Disease control
Last updated Jun 27, 2026 12:37 UTC
-
New drug combo aims to halt artery plaque after heart attacks
Disease control Recruiting nowThe CAPRA-EVO trial is a single-center, randomized, open-label study with blinded endpoint assessment comparing early evolocumab plus standard lipid-lowering therapy versus standard-of-care lipid-lowering therapy in patients with acute coronary syndrome after successful percutane…
Phase: PHASE4 • Sponsor: West China Hospital • Aim: Disease control
Last updated Jun 27, 2026 13:05 UTC
-
Inhaled powder could offer rapid migraine relief without needles
Symptom relief Recruiting nowThis study is testing an investigational inhaled migraine medication to see how well it works, how safe it is, and how well people tolerate it. Adults with migraine will receive both the study medication (ASY202) and a placebo (inactive treatment) at different times during the st…
Phase: PHASE2 • Sponsor: Aspeya, Inc. • Aim: Symptom relief
Last updated Jul 23, 2026 00:00 UTC
-
New drug aims to wake up transplanted kidneys faster
Disease control TerminatedA Phase 3 Study to Evaluate the Efficacy and Safety of Pegcetacoplan in Adults at High Risk of Delayed Graft Function (DGF) Following Kidney Allograft Transplantation
Phase: PHASE3 • Sponsor: Apellis Pharmaceuticals, Inc. • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
New monkeypox vaccine JT118 enters first human tests
⭐️ VACCINE ⭐️ Recruiting nowThis study is a randomized, double-blind, placebo-controlled Phase I clinical trial representing the first-in-human (FIH) investigation of the Monkeypox recombinant protein vaccine JT118. The primary objectives are to evaluate the safety, tolerability, and immunogenicity of two d…
Phase: PHASE1 • Sponsor: Shanghai JunTop Biosciences Co., LTD • Aim: ⭐️ VACCINE ⭐️
Last updated Jun 27, 2026 13:03 UTC
-
New antibody therapy targets Hard-to-Treat prostate cancer
Disease control Recruiting nowThis study is being conducted to learn more about the safety, tolerability, and effectiveness of an experimental treatment for metastatic prostate cancer called AZD8359. The study is split into different modules which will look at AZD8359 delivered by different methods. The study…
Phase: PHASE1, PHASE2 • Sponsor: AstraZeneca • Aim: Disease control
Last updated Jul 15, 2026 00:00 UTC
-
New drug duo aims to wipe out esophageal tumors before surgery
Disease control Recruiting nowThis study aims to explore the efficacy and safety of anlotinib combined with bemocizumab as neoadjuvant therapy for resectable esophageal squamous cell carcinoma, with the goal of improving the pathological complete response (pCR) rate and margin-negative resection(R0) resection…
Phase: NA • Sponsor: Nanfang Hospital, Southern Medical University • Aim: Disease control
Last updated Jun 27, 2026 13:03 UTC
-
AI could revolutionize liver cancer treatment by predicting who will benefit most
Knowledge-focused Not yet recruitingThis study aims to prospectively validate a retrospective cohort-derived AI-based multimodal model and explore tumor heterogeneity and the immune microenvironment to guide TACE combined with immunotherapy and targeted therapy in HCC.
Sponsor: Gao-jun Teng • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:33 UTC
-
New drug combo aims to tame rare inflammatory disease
Disease control Not yet recruitingThe primary objective of the study is to evaluate the efficacy and safety of goflikicept (GFC) and olokizumab (OKZ) in patients with Still's disease
Phase: PHASE3 • Sponsor: R-Pharm International, LLC • Aim: Disease control
Last updated Jun 27, 2026 13:03 UTC
-
New heart ablation method aims to stop AFib recurrence
Disease control Not yet recruitingThe primary objective of this study is to determine whether low-voltage areas (LVA)-guided catheter ablation combined with superior vena cava (SVC) isolation and pulmonary vein isolation (PVI), performed using the balloon-in-basket Volt™ pulsed field ablation PFA system, is super…
Phase: NA • Sponsor: University of Luebeck • Aim: Disease control
Last updated Jun 27, 2026 12:36 UTC
-
New drug combo targets Hard-to-Treat pancreatic cancer
Disease control Recruiting nowTo find out if the combination of BMS-986504 plus neoadjuvant/adjuvant chemotherapy and surgery (Cohort 1) or BMS-986504 plus standard of care chemotherapy (Cohorts 2 and 3) can help to control pancreatic cancer.
Phase: PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Jun 27, 2026 13:04 UTC
-
New radioactive 'Smart Bomb' targets Hard-to-Treat lung cancer
Disease control Recruiting nowThe purpose of this study is to evaluate the safety, tolerability, dosimetry and preliminary efficacy of \[212Pb\]Pb-MP0712, in patients aged ≥18 years with Small Cell Lung Cancer and other locally advanced or metastatic DLL3 positive tumors.
Phase: PHASE1, PHASE2 • Sponsor: Molecular Partners AG • Aim: Disease control
Last updated Jun 27, 2026 12:37 UTC
-
Less may be more: smaller lung surgery tested after powerful Pre-Treatment
Disease control Recruiting nowThis study is a prospective, randomized controlled multicenter clinical trial. The study population consisted of non-small cell lung cancer(NSCLC) patients in stage IIA-IIIB (IASLC 9th edition) who received immunotherapy combined with platinum based dual drug chemotherapy before …
Phase: NA • Sponsor: Wen-zhao ZHONG • Aim: Disease control
Last updated Jun 27, 2026 13:00 UTC
-
New hope for Hard-to-Treat breast cancer: drug combo targets resistant tumors
Disease control Not yet recruitingAlthough treatments for breast cancer have improved, 20-30% of patients with early disease develop metastases (cancer that spreads to other parts of the body). Among the different types of breast cancer, hormone-sensitive cancers that do not overexpress the HER2 protein (HR+/HER2…
Phase: PHASE2 • Sponsor: UNICANCER • Aim: Disease control
Last updated Jun 27, 2026 12:35 UTC
-
Magic mushrooms take on OCD: new trial tests doses for relief
Symptom relief Recruiting nowThe study tries to improve our treatments for people who have obsessive-compulsive disorder (OCD) by testing psilocybin, a mind altering drug that changes activity in brain areas involved in OCD. 30 patients with moderate or more severe OCD who are not taking mind altering medica…
Phase: PHASE1 • Sponsor: Francisco A Moreno • Aim: Symptom relief
Last updated Jul 25, 2026 00:00 UTC
-
Could a Brain-Zapping implant tame cluster headaches?
Disease control Recruiting nowThe purpose of this clinical trial is to evaluate the safety and effectiveness of the Occipital Nerve Stimulation System (ONSS) in treating chronic cluster headache in adults. The study aims to answer the following questions: * What adverse events or medical complications occur…
Phase: NA • Sponsor: Man and Science, SA • Aim: Disease control
Last updated Jul 02, 2026 00:00 UTC